Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Indiana University
OHSU Knight Cancer Institute
Emory University
Dana-Farber Cancer Institute
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center